Sermorelin
|
FDA approved and discontinued
|
July, 2008
|
IN SEPTEMBER 1997, SERMORELIN WAS APPROVED FOR THE TREATMENT OF GROWTH
HORMONE DEFICIENCY IN CHILDREN
|
Examorelin
|
Interrupted
|
|
|
Tabimorelin
|
Interrupted
|
AT
|
IT SEEMS INTERRUPTED.
|
Pralmorelin (i.v.)
|
Approved in Japan
|
October, 2004
|
DIAGNOSIS OF GROWTH HORMONE DEFICIENCY IN ADULTS AND CHILDREN
(> 4 YEARS).
|
Ipamorelin
|
Interrupted
|
|
|
Ulimorelin
|
Active
|
March, 2017
|
EVALUATING THE EFFECT OF ULIMORELIN IN PATIENTS WITH INTOLERANCE OF
ENTERAL FEEDING
|
Relamorelin
|
Currently evaluated by the FDA
|
October, 2016
|
TREATMENT OF DIABETIC GASTROPARESIS.
|
TZP-102
|
Active
|
2013
|
FDA GIVES TZP-102 A QUICK DESIGNATION FOR TREATMENT OF DIABETIC
GASTROPARESIS IN 2009.
|
Tesamorelin
|
FDA approved
|
November, 2010
|
REDUCTION OF EXCESS ABDOMINAL FAT IN HIV INFECTED
|
|
|
|
PATIENTS WITH LIPODYSTROPHY.
|
Capromorelin (oral)
|
FDA approved
|
June, 2016
|
APPETITE STIMULATION IN DOGS WITH DECREASED APPETITE.
|
Anamorelin
|
Requested for approval at EMA
|
November, 2015
|
CACHEXIA ASSOCIATED WITH NSCLC.
|
Macimorelin
|
Requested for FDA approval
|
February, 2017
|
DIAGNOSIS OF GROWTH HORMONE DEFICIENCY IN ADULTS.
|